glp-1 for nash Why are agonists being used to treat patients with nonalcoholic fatty liver disease? Multiple target tissue effects of

I was on Januvia, Metformin and Gliclazide and exercising *hard* at the gym, but not losing body fat very quickly, up at 36% body fat

: -10 +50

In my practice, I have seen countless women who, despite their best efforts, cannot achieve their weight loss goals

04.07.25 Study linked semaglutide and vision impairment A study published in BMC Medicine studied patients who are taking semaglutide drugs and reported certain vision conditions

Patients with MASH, especially those with metabolic diseases like obesity or type 2 diabetes, are at greater risk for adverse cardiovascular events and increased illness and mortality